Epirubicin class of drug?

Epirubicin is a member of the anthracycline class of chemotherapeutic agents.

| Feature | Details |
|--------|---------|
| Drug class | Anthracycline antibiotic (cardiotoxic anthracycline) |
| Mechanism of action | Intercalates into DNA, inhibits topoisomerase II, and generates free radicals that damage DNA. |
| Common uses | Breast cancer (adjuvant/neoadjuvant), ovarian cancer, uterine sarcoma, and other solid tumours; often used in combination regimens (e.g., AC—cyclophosphamide + epirubicin). |
| Key pharmacologic considerations | Cardiac toxicity (dose‑dependent), cumulative cardiomyopathy risk; requires baseline and periodic cardiac monitoring. |
| Formulations | Intravenous infusion; tablets are not available. |
| Contraindications | Known hypersensitivity, significant pre‑existing heart disease, pregnancy (category C). |

In short, epirubicin is an anthracycline chemotherapy drug that works by disrupting DNA replication and is used to treat various solid tumours, especially breast cancer.